Results 51 to 60 of about 6,695 (175)

From Data to Decisions: How Machine Learning and Generative Artificial Intelligence Are Redefining Precision Medicine in Kidney Transplantation

open access: yesOrgan Medicine, Volume 3, Issue 2, Page 102-118, June 2026.
This review evaluates how machine learning, multimodal integration, and generative AI optimize kidney transplant outcomes. These tools enable superior prediction and personalized therapy but face hurdles in data volume, generalizability, and ethics. Future clinical adoption depends on continued innovation and multidisciplinary collaboration to overcome
Maoxin Liao, Cheng Yang
wiley   +1 more source

BK Polyomavirus in Renal Transplantation [PDF]

open access: yesGeneral Medicine: Open Access, 2014
BK virus is a human polyomavirus that rarely causes disease, except in immune-compromised patients. Evidence of prior BK Virus (BKV) infection is highly prevalent in the general population, and although it rarely causes significant morbidity at primary infection, reactivation of BKV after kidney transplantation is recognized as a cause of BKV ...
openaire   +1 more source

The human polyomavirus BK: Potential role in cancer [PDF]

open access: yesJournal of Cellular Physiology, 2005
AbstractIn human cancer, a role has been suggested for the human polyomavirus BK, primarily associated with tubulointerstitial nephritis and ureteric stenosis in renal transplant recipients, and with hemorrhagic cystitis in bone marrow transplant (BMT) recipients.
FIORITI, DANIELA   +6 more
openaire   +5 more sources

Nonclassical MHC‐I Molecules: Emerging Therapeutic Targets in Next‐Generation Immunotherapy

open access: yesMedComm, Volume 7, Issue 5, May 2026.
Immunotherapies dependent on classical MHC‐I molecules face significant challenges, including extreme polymorphism and frequent downregulation in pathological conditions. This review discusses how nonclassical MHC‐I molecules (HLA‐E, HLA‐F, HLA‐G, CD1, MR1) may potentially circumvent these limitations through restricted genetic diversity, stable ...
Wanlin He, Andrew J. McMichael
wiley   +1 more source

Prevalence of anti-BK polyomavirus IgG in A Sample of Iraqi renal transplant recipients

open access: yesDiyala Journal of Medicine, 2022
Background: BK virus, a human polyomavirus, causes nephropathy and allograft loss in renal transplant recipients. Although it was discovered in 1971, understanding of the humoral immune response to BKV is limited.
Ghufran Hammoodi Abed ,   +5 more
doaj   +1 more source

Paediatric renal transplantation: Paediatric surgeons' perspective

open access: yesSurgical Practice, Volume 30, Issue 2, Page 117-122, May 2026.
Abstract Renal transplantation is the most effective treatment for paediatric end‐stage renal disease (ESRD), offering advantages in survival, growth and neurocognitive development that surpass other renal replacement therapies (RRT). The paediatric setting, however, introduces distinct complexities that distinguish it from adult practice.
Adrian Chi‐heng Fung   +3 more
wiley   +1 more source

BK POLYOMAVIRUS-INFECTED DECOY CELLS IN URINE CYTOLOGY SPECIMENS OF RENAL TRANSPLANT RECIPIENTS

open access: yesThe Iraqi Journal of Medical Sciences, 2016
Background:BK polyomavirus is one of the common post-transplant viral infections, affecting ?15% of renal transplantation recipients (RTR), leading to graft loss in more than half of cases.
Asmaa B. Al-Obaidi   +6 more
doaj   +4 more sources

Prevalence and Molecular Profiling of Merkel Cell Polyomavirus in Patients With Monkeypox Virus Infection

open access: yesJournal of Medical Virology, Volume 98, Issue 4, April 2026.
ABSTRACT Mpox, caused by Monkeypox virus (MPXV), is associated with mucosal involvement and immune modulation that may influence viral coinfections. Merkel Cell Polyomavirus (MCPyV), a ubiquitous virus capable of lifelong persistence, was investigated in 66 Mpox patients enrolled at Lazzaro Spallanzani National Institute for Infectious Diseases (Rome ...
Sara Passerini   +8 more
wiley   +1 more source

A polyomavirus peptide binds to the capsid VP1 pore and has potent antiviral activity against BK and JC polyomaviruses

open access: yeseLife, 2020
In pursuit of therapeutics for human polyomaviruses, we identified a peptide derived from the BK polyomavirus (BKV) minor structural proteins VP2/3 that is a potent inhibitor of BKV infection with no observable cellular toxicity.
Joshua R Kane   +12 more
doaj   +1 more source

Manufacturing and clinical applications of non‐CAR‐T immune effector cells

open access: yes
Transfusion, EarlyView.
Thane Kubik   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy